In diseases of the central nervous system (CNS) such as Multiple Sclerosis (MS), myelinating cells are the principal affected cells. Following pathological loss of myelin, remyelination by oligodendrocyte precursors (OPC) occurs but becomes increasingly incomplete and eventually fails in the majority of lesions. Understanding the molecular basis of myelination and remyelination and the regulation ...